OraSure Technologies Inc (OSUR)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$2.85

Buy

$3.20

arrow-up$0.05 (+1.69%)

Prices updated at 16 May 2026, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD

OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. John Patrick Kenny
CEO
Ms. Carrie Eglinton Manner
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
500
Head office
220 East First Street
Bethlehem
United States
18015
mobile
+1 610 882-1820
letter
investorinfo@orasure.com

Key personnel

Salary
Mr. John D. Bertrand
Independent Director
-
Mr. Robert W. McMahon
Independent Director
0.08m
Ms. Carrie Eglinton Manner
Director, President and Chief Executive Officer
0.72m
Mr. John Patrick Kenny
Chairman of the Board
0.08m
Ms. Michele Anthony
Senior Vice President, Controller and Chief Accounting Officer
-
Mr. Lelio Marmora
Independent Director
0.07m
Dr. Nancy J. Gagliano, M.D.
Independent Director
0.08m
Mr. Kenneth J. McGrath
Chief Financial Officer
0.51m
Mr. Steven Kyle Boyd
Independent Director
0.01m

Top 5 shareholders

No. of shares
BlackRock Inc6,447,181
Private Management Group Inc5,396,219
Vanguard Group Inc4,102,632
Neuberger Berman Investment Advisers LLC3,984,854
Neuberger Berman Group LLC3,984,854

Director dealings

Action
28 Nov 2025-
28 Oct 2025-
08 Aug 2025-
31 Jul 2025-
04 Jun 2025-
04 Jun 2025-
04 Jun 2025-
14 May 2025-
13 May 2025-
14 May 2025-
13 May 2025-
14 May 2025-
13 May 2025-
14 May 2025-
13 May 2025-
14 May 2025-
13 May 2025-
01 Mar 2025-
01 Mar 2025-
01 Mar 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.